Value Bridge — UCSD MEDICAL CENTER
Current $-220M → Target $-152M (+$67.7M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-219.5M
Current EBITDA
$-151.9M
Target EBITDA
+$67.7M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$15.3M
Payer Mix Optimization
$36.7M
Cost to Collect Reduction
$12.2M
Clean Claim Improvement
$9.2M
Volume & Rate Growth
$61.2M
What This Means
The 7-lever model projects a 0% EBITDA uplift from $-220M to $-152M. The highest-impact lever is Volume & Rate Growth at $24.5M probability-weighted.
IC talking point: "We see $68M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $744M in equity value creation."